Brokerages Set Phreesia, Inc. (NYSE:PHR) Target Price at $31.15

Phreesia, Inc. (NYSE:PHR) has earned a consensus rating of “Buy” from the thirteen ratings firms that are covering the firm, Marketbeat.com reports. Thirteen investment analysts have rated the stock with a buy rating. The average 12-month target price among brokerages that have issued a report on the stock in the last year is $31.15.

Several research analysts have commented on PHR shares. Needham & Company LLC reissued a “buy” rating and issued a $29.00 price objective on shares of Phreesia in a research report on Friday, January 10th. Truist Financial raised their price objective on Phreesia from $31.00 to $34.00 and gave the company a “buy” rating in a research report on Wednesday, December 11th. Piper Sandler reissued an “overweight” rating and issued a $33.00 price objective (up from $31.00) on shares of Phreesia in a research report on Wednesday, January 29th. KeyCorp raised their price objective on Phreesia from $28.00 to $30.00 and gave the company an “overweight” rating in a research report on Wednesday, January 8th. Finally, JMP Securities reissued a “market outperform” rating and issued a $30.00 price objective on shares of Phreesia in a research report on Tuesday, December 10th.

Insider Buying and Selling

In other Phreesia news, CFO Balaji Gandhi sold 4,813 shares of Phreesia stock in a transaction that occurred on Monday, January 27th. The stock was sold at an average price of $27.48, for a total value of $132,261.24. Following the completion of the transaction, the chief financial officer now directly owns 144,933 shares in the company, valued at $3,982,758.84. The trade was a 3.21 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, COO Evan Roberts sold 2,681 shares of Phreesia stock in a transaction that occurred on Wednesday, January 8th. The shares were sold at an average price of $27.95, for a total value of $74,933.95. Following the completion of the transaction, the chief operating officer now owns 769,993 shares of the company’s stock, valued at approximately $21,521,304.35. The trade was a 0.35 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 167,173 shares of company stock worth $4,221,400. Corporate insiders own 5.80% of the company’s stock.

Institutional Investors Weigh In On Phreesia

A number of hedge funds have recently made changes to their positions in PHR. ExodusPoint Capital Management LP raised its holdings in shares of Phreesia by 448.6% during the fourth quarter. ExodusPoint Capital Management LP now owns 174,971 shares of the company’s stock valued at $4,402,000 after buying an additional 143,077 shares during the last quarter. Norges Bank bought a new stake in shares of Phreesia during the fourth quarter valued at approximately $2,804,000. Champlain Investment Partners LLC raised its holdings in shares of Phreesia by 4.1% during the third quarter. Champlain Investment Partners LLC now owns 2,503,837 shares of the company’s stock valued at $57,062,000 after buying an additional 97,847 shares during the last quarter. Nicholas Company Inc. bought a new stake in shares of Phreesia during the fourth quarter valued at approximately $2,452,000. Finally, State Street Corp raised its holdings in Phreesia by 7.1% during the third quarter. State Street Corp now owns 1,327,586 shares of the company’s stock worth $30,256,000 after purchasing an additional 88,517 shares in the last quarter. Institutional investors own 92.10% of the company’s stock.

Phreesia Trading Down 0.5 %

Shares of PHR opened at $28.42 on Monday. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.04. The firm has a market capitalization of $1.65 billion, a P/E ratio of -19.33 and a beta of 0.96. The stock’s fifty day simple moving average is $26.28 and its 200 day simple moving average is $23.55. Phreesia has a twelve month low of $17.07 and a twelve month high of $29.90.

Phreesia (NYSE:PHR) last issued its earnings results on Monday, December 9th. The company reported ($0.25) earnings per share for the quarter, topping the consensus estimate of ($0.29) by $0.04. The business had revenue of $106.80 million for the quarter, compared to analyst estimates of $106.33 million. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The business’s quarterly revenue was up 16.6% on a year-over-year basis. During the same period last year, the company posted ($0.58) EPS. On average, equities research analysts forecast that Phreesia will post -1.1 earnings per share for the current year.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.